Fady Ibrahim is a Principal Scientist in Pharmaceutical Sciences at Pfizer Worldwide R&D in Groton, CT. Fady has a BSc in pharmacy and a Ph.D. in pharmaceutical sciences from the University of Houston, TX. His Ph.D. started to develop his core research interests of formulation, pharmacokinetics and biopharmaceutics.
He moved to The University of British Columbia, Vancouver, Canada, as a postdoc to work on developing an oral lipid-based formulation for amphotericin B. Then, he moved to Pfizer in Groton to join the Biopharmaceutics Group. His role in the Biopharmaceutics Group is focused on translational biopharmaceutics.
His research focuses on understanding oral absorption and the effect of physicochemical properties of drug substance and drug product on oral absorption. He is interested in studying the intestinal precipitation of weakly basic compounds from various dosage forms. His main areas of expertise are dissolution, formulation, PK modeling and simulation, and IVIVC.